IGM Biosciences Inc (NAS:IGMS)
$ 9.22 -0.07 (-0.75%) Market Cap: 544.20 Mil Enterprise Value: 295.49 Mil PE Ratio: 0 PB Ratio: 3.40 GF Score: 36/100

IGM Biosciences Inc at Stifel Virtual Healthcare Conference Transcript

Nov 16, 2020 / 08:20PM GMT
Release Date Price: $54 (+0.99%)
Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director

All right. Good afternoon. I'm Stephen Willey, one of the Senior Biotech Analysts here at Stifel. I'm glad to have with us here today from IGM Biosciences, CEO, Fred Schwarzer. We're just going to have kind of an informal discussion about some of the most relevant topics right now, ASH being obviously one of them.

I think there is kind of a portal that is available, if you have any kind of pressing questions, you can enter them into the portal, and we'll try to get them asked and answered as appropriate. But Fred, thanks for joining us today. I don't know if you want to make any kind of introductory comments at all before we jump into Q&A at all?

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Well, other than to say thank you very much. It's always a pleasure to talk with you, and we always enjoy our conversations. And why don't we just dive in because we're very excited about our ASH abstract data. I'm sure you've got to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot